FDA Approved: CALCIUM ACETATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for calcium acetate capsules (667 mg) by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• Calcium Acetate Capsules 667 mg (Calcium acetate)

Snippet

SUPPL AP for CALCIUM ACETATE (CALCIUM ACETATE)